You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: little evidence exists on the benefits and harms of screening for and treating gestational diabetes

https://doi.org/10.1136/ebm.13.6.172

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    T A Hillier

    Dr T A Hillier, Kaiser Permanente Northwest, Portland, OR, USA

    QUESTION

    What are the benefits and harms of screening for and treating gestational diabetes mellitus (GDM)?

    REVIEW SCOPE

    The review sought to answer the following questions: Are screening tests for GDM accurate? Does screening and treatment for GDM reduce perinatal morbidity and mortality in the mother and infant? What are the harms associated with these interventions? Neonatal outcomes were mortality and morbidity; maternal outcomes were mortality, pre-eclampsia, and pregnancy-induced hypertension.

    REVIEW METHODS

    Medline and 5 other databases (2000 to Nov 2007) and references were searched for studies that used a 1-step or 2-step screening method and recognised diagnostic criteria for GDM. Experts were …

    View Full Text

    Footnotes

    • Source of funding: Agency for Healthcare Research and Quality.